CY2482B1 - Paroxetine in treatment of depression. - Google Patents

Paroxetine in treatment of depression.

Info

Publication number
CY2482B1
CY2482B1 CY0400079A CY0400079A CY2482B1 CY 2482 B1 CY2482 B1 CY 2482B1 CY 0400079 A CY0400079 A CY 0400079A CY 0400079 A CY0400079 A CY 0400079A CY 2482 B1 CY2482 B1 CY 2482B1
Authority
CY
Cyprus
Prior art keywords
paroxetine
depression
treatment
Prior art date
Application number
CY0400079A
Other languages
English (en)
Inventor
Maurice Gleason
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of CY2482B1 publication Critical patent/CY2482B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CY0400079A 1996-03-20 2004-11-05 Paroxetine in treatment of depression. CY2482B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9605828.4A GB9605828D0 (en) 1996-03-20 1996-03-20 Treatment method

Publications (1)

Publication Number Publication Date
CY2482B1 true CY2482B1 (en) 2005-06-03

Family

ID=10790697

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0400079A CY2482B1 (en) 1996-03-20 2004-11-05 Paroxetine in treatment of depression.

Country Status (8)

Country Link
US (1) US6121291A (xx)
EP (2) EP0893997B1 (xx)
JP (1) JP2000513331A (xx)
CY (1) CY2482B1 (xx)
DE (1) DE69721756T2 (xx)
ES (1) ES2199357T3 (xx)
GB (1) GB9605828D0 (xx)
WO (1) WO1997034602A1 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2193939C (en) * 1996-12-24 2002-02-12 K.S. Keshava Murthy Useful form of anhydrous paroxetine hydrochloride
EP0975595B9 (en) 1997-04-07 2009-09-16 Georgetown University Analogs of cocaine
GB9812941D0 (en) * 1998-06-16 1998-08-12 Smithkline Beecham Plc Method of treatment
ES2159260B1 (es) * 1999-06-22 2002-05-01 Smithkline Beechan Plc Nueva composicion de metanosulfonato de paroxetina
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
AU2003237524A1 (en) * 2002-07-08 2004-01-23 University Of Florida Use of ssri inhibitors to prevent or ameliorate trauma-related psychological disorders
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
WO2006023347A1 (en) * 2004-08-20 2006-03-02 Alpharma, Inc. Paroxetine formulations
EP1948646A2 (en) * 2005-11-14 2008-07-30 Auspex Pharmaceuticals Inc. Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine
TWI646971B (zh) * 2015-12-04 2019-01-11 鄭恩哲 阻斷海洛因或嗎啡毒品中毒路徑的點滴處方及其應用
US11730706B1 (en) * 2022-07-07 2023-08-22 Antecip Bioventures Ii Llc Treatment of depression in certain patient populations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
US5114976A (en) * 1989-01-06 1992-05-19 Norden Michael J Method for treating certain psychiatric disorders and certain psychiatric symptoms
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation

Also Published As

Publication number Publication date
EP1300144A3 (en) 2003-05-21
EP0893997B1 (en) 2003-05-07
DE69721756D1 (de) 2003-06-12
EP1300144A2 (en) 2003-04-09
US6121291A (en) 2000-09-19
JP2000513331A (ja) 2000-10-10
GB9605828D0 (en) 1996-05-22
ES2199357T3 (es) 2004-02-16
WO1997034602A1 (en) 1997-09-25
DE69721756T2 (de) 2003-12-04
EP0893997A1 (en) 1999-02-03

Similar Documents

Publication Publication Date Title
GB9700899D0 (en) Novel treatment
CY2482B1 (en) Paroxetine in treatment of depression.
HK1018271A1 (en) Substituted benzylamines and their use for the treatment of depression
AU2418499A (en) Org-5222 in the treatment of depression
GB9619492D0 (en) Novel treatment
EP0921803A4 (en) METHOD FOR PREVENTING AND TREATING PESTVIRUS INFECTIONS AND RELATED DISEASES
ZA976593B (en) Novel treatment
GB9608657D0 (en) Novel treatment
GB9708400D0 (en) Sterilising arrangement and method
ZA995262B (en) Massage composition and method.
GB9625795D0 (en) Novel treatment
GB2336539B (en) Wood treatment
GB9620085D0 (en) Cosmetic treatment
GB9721978D0 (en) Treatment of depression
IL141880A0 (en) Treatment of depression
GB9612752D0 (en) Novel treatment
ZA986485B (en) Levobupivacaine and its use.
ZA986484B (en) Levobupivacaine and its use.
GB9707104D0 (en) An improvement in the treatment of bio-waste
GB9617762D0 (en) Treatment
GB9716742D0 (en) Treatment
GB9602405D0 (en) Anti-smoking treatment, therapy and illness prevention
GB9708700D0 (en) Treatment of depression
ZA9710056B (en) Aids treatment agent.
GB9715427D0 (en) Wood care treatment preservative